Stay informed on upcoming cosmetic regulatory changes. Learn about the deadlines and new requirements for compliance in 2024.
News
Cosmetics: upcoming regulatory deadlines
Stay informed on upcoming cosmetic regulatory changes. Learn about the deadlines and new requirements for compliance in 2024.
Meet Obelis at Cosmoprof Bologna 2024 for Expert Guidance on EU, UK & US Cosmetic Regulations
Find us at Hall 16, Booth H/32 I/31 to explore Regulatory Strategies for Cosmetics in Global Markets.
How to prepare for the proposed extension for IVD medical devices
The EU’s proposed extension for IVD medical devices aims to prevent shortages. Manufacturers must prepare by meeting IVDR requirements promptly.
Obelis Group at Arab Health 2024 – Here is a successful story in medical device regulations
Obelis Group at Arab Health 2024 – Here is a successful story in medical device regulations
Main regulatory developments to follow in 2024
Find out the 2024 updates regarding Medical devices, In-Vitro diagnostics, cosmetics, construction products, toys and more!
Compliance Success Stories: Home and Body Company – Building Trust Through Compliance for International Expansion
Explore Home and Body Co’s exceptional path through cosmetic compliance and how their partnership with Obelis Regulatory Services enabled international growth while maintaining a strong focus on product safety and regulatory excellence.
New Free Sales Certificate under MDR & IVDR for EU non-EU manufacturers!
The Belgian competent authority (AFMPS/FAGG) has updated the form for the Free Sales Certificates (FSC) under the Medical Devices Regulation 2017/745 (MDR) and the In Vitro Diagnostic Devices Regulation 2017/746 (IVDR).
MoCRA terminology: an insight into the main terms of the new American law on cosmetics
Learn the main terms of the new American law on cosmetics: MoCRA.
Contract manufacturers and brand owners: what has changed with MoCRA
MoCRA has ushered in significant changes for cosmetic brand owners and contract manufacturers, necessitating the revision of agreements and the establishment of clear responsibilities to meet the new regulatory standards.